Kieff D A, Bhattacharyya N, Siegel N S, Salman S D
Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, USA.
Otolaryngol Head Neck Surg. 1999 Jan;120(1):57-61. doi: 10.1016/S0194-5998(99)70370-0.
Despite the fact that peritonsillar abscess is the most common complication of acute tonsillitis, the treatment of peritonsillar abscess remains controversial. One element of controversy is the choice of antibiotics after drainage of the abscess. In an attempt to assess the effect of antibiotic choice on the treatment of peritonsillar abscess, we conducted a retrospective review of records from patients with peritonsillar abscess treated with incision and drainage. Our review identified 103 patients, comprising two groups: 58 patients treated with broad-spectrum intravenous antibiotics and 45 patients treated with intravenous penicillin alone. These patients were hospitalized after incision and drainage, and therefore their clinical courses and responses to therapy could be rigorously assessed. Characterization of illness based on patient age, temperature, and white blood cell count revealed similar severity of illness between the two groups. Comparison of clinical outcomes with respect to hours hospitalized (mean 44.3 +/- 6.6 and 38.3 +/- 7.1 hours, 95% confidence interval, for broad-spectrum and penicillin groups, respectively) and mean hours febrile (16.9 +/- 5.0 and 13.3 +/- 4.2 hours, 95% confidence interval) were not statistically significantly different (p = 0.222 and 0.269, respectively) between groups, indicating that broad-spectrum antibiotics failed to show greater efficacy than penicillin in the treatment of these patients. The microbiologic characteristics of these infections, failures of therapy, and complication rates were similar to those reported in the literature. These results suggest that intravenous penicillin remains an excellent choice for therapy in cases of peritonsillar abscess requiring parenteral antibiotics after drainage.
尽管扁桃体周围脓肿是急性扁桃体炎最常见的并发症,但扁桃体周围脓肿的治疗仍存在争议。争议的一个方面是脓肿引流后抗生素的选择。为了评估抗生素选择对扁桃体周围脓肿治疗的影响,我们对接受切开引流治疗的扁桃体周围脓肿患者的记录进行了回顾性分析。我们的分析确定了103例患者,分为两组:58例接受广谱静脉抗生素治疗,45例仅接受静脉青霉素治疗。这些患者在切开引流后住院,因此可以严格评估他们的临床病程和对治疗的反应。根据患者年龄、体温和白细胞计数对病情进行的特征分析显示,两组病情严重程度相似。比较两组的临床结局,住院小时数(广谱抗生素组和青霉素组分别为平均44.3±6.6小时和38.3±7.1小时,95%置信区间)和平均发热小时数(16.9±5.0小时和13.3±4.2小时,95%置信区间)在两组之间无统计学显著差异(p分别为0.222和0.269),这表明在治疗这些患者时,广谱抗生素并未显示出比青霉素更高的疗效。这些感染的微生物学特征、治疗失败情况和并发症发生率与文献报道相似。这些结果表明,对于引流后需要肠外抗生素治疗的扁桃体周围脓肿病例,静脉青霉素仍然是一种很好的治疗选择。